Is MI Considered Coronary Artery Disease?
Yes, myocardial infarction (MI) is typically considered a manifestation of coronary artery disease (CAD), but importantly, MI can occur both with and without obstructive CAD, and the relationship is more nuanced than a simple equivalence.
The Relationship Between MI and CAD
MI represents an acute clinical event, while CAD describes the underlying pathological condition of the coronary arteries. The 2024 nomenclature guidelines 1 emphasize that traditional terminology like "coronary artery disease" has become restrictive and fails to capture the full spectrum of myocardial ischemic conditions.
Type 1 MI and CAD
- Type 1 MI is directly related to atherosclerotic plaque rupture, ulceration, fissuring, or erosion with resulting coronary thrombus 2
- This type is fundamentally caused by underlying CAD, though patients may occasionally have non-obstructive or even no CAD on angiography (5-20% of cases, particularly in women) 2
- When MI occurs due to atherosclerotic plaque disruption, it represents an acute manifestation of chronic CAD 3
Type 2 MI and CAD
- Type 2 MI results from oxygen supply-demand mismatch unrelated to acute coronary atherothrombosis 2
- The presence and severity of underlying CAD significantly influences the ischemic threshold and risk of Type 2 MI 4
- CAD serves as an independent predictor of cardiovascular death and recurrent MI in Type 2 MI patients 4
MI Without Obstructive CAD (MINOCA)
A critical distinction: approximately 15% of MI patients have no obstructive CAD at angiography 5. This population:
- Is more commonly women (50% vs 23% in obstructive CAD) 5
- Is younger on average 5
- Still faces significant risk: 2-year mortality or reinfarction rate of 4.6%, which is double that of age-matched patients without cardiovascular disease 5
- Is NOT a benign condition despite the absence of obstructive disease 5
Mechanisms in MINOCA
Intravascular ultrasound and cardiac MRI studies reveal 6:
- Plaque rupture in nearly 40% of cases
- Other mechanisms include vasospasm, embolism, dissection, or branch occlusion
- Myocarditis and infiltrative diseases as non-ischemic causes
Clinical Classification Framework
The evolving nomenclature 1 proposes moving away from restrictive terms like "coronary artery disease" toward:
- Acute myocardial ischemic syndromes (including STEMI, NSTEMI, and ACS)
- Non-acute myocardial ischemic syndromes (replacing terms like "stable CAD" or "chronic coronary disease")
This framework acknowledges both obstructive epicardial and non-obstructive mechanisms, including microvascular dysfunction and vasospastic disorders 1.
Prognostic Implications
MI classification predicts future heart failure risk differently than CAD presence alone 7:
- Initial MI presentation carries the highest long-term heart failure risk (adjusted HR 1.6) compared to stable angina
- MI with CABG also shows elevated risk (HR 1.5)
- Nearly 50% of initial CAD diagnoses occur with hospitalization, placing patients at high early heart failure risk 7
Treatment Implications
Despite the absence of obstructive CAD, MINOCA patients should receive guideline-recommended secondary prevention 6, including:
- Antiplatelet therapy
- Antiatherosclerotic medications
- Standard post-MI management
The key clinical pitfall is undertreating MINOCA patients due to the absence of obstructive disease—these patients still have double the cardiovascular risk of matched controls without CVD 5 and receive "triple therapy" secondary prevention less frequently (81% vs 94%) 5.